Long-Term Tolerability and Efficacy of Golimumab in Active Nonradiographic Axial Spondyloarthritis: Results from the Open-Label Extension of a Randomized, Double-Blind Study

被引：0
|
作者：
van der Heijde, Desiree [1 ]
Dougados, Maxime [2 ]
Maksymowych, Walter [3 ]
Bergman, Gina [4 ]
Curtis, Sean P. [4 ]
Tzontcheva, Anjela [4 ]
Philip, George [4 ]
Huyck, Susan [4 ]
Sieper, Joachim [5 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Paris Descartes Univ, Paris, France
[3] Univ Alberta, Edmonton, AB, Canada
[4] Merck & Co Inc, Kenilworth, NJ USA
[5] Univ Clin Benjamin Franklin, Berlin, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2854
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
    Feist, Eugen
    Nasonov, Evgeny
    Luggen, Michael
    Fatenejad, Saeed
    Grishin, Sergey
    Samsonov, Mikhail
    Fleischmann, Roy
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
  • [32] An Interim Analysis Of Long-Term Outcomes In Patients Treated With Bosentan In The Double-Blind Or Open-Label Extension To The Early Trial
    Simonneau, G.
    Galie, N.
    Hoeper, M. M.
    Kusic-Pajic, A.
    Morganti, A.
    Rubin, L. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [33] Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia
    Morse, Anne Marie
    Dauvilliers, Yves
    Arnulf, Isabelle
    Thorpy, Michael J.
    Foldvary-Schaefer, Nancy
    Chandler, Patricia
    Chen, Abby
    Hickey, Luke
    Black, Jed
    Bogan, Richard K.
    JOURNAL OF CLINICAL SLEEP MEDICINE, 2023, 19 (10): : 1811 - 1822
  • [34] Efficacy and safety of alogliptin added to sulfonylurea in Japanese patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
    Seino, Yutaka
    Hiroi, Shinzo
    Hirayama, Masashi
    Kaku, Kohei
    JOURNAL OF DIABETES INVESTIGATION, 2012, 3 (06) : 517 - 525
  • [35] Efficacy and safety of alogliptin added to pioglitazone in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label long-term extension study
    Kaku, K.
    Itayasu, T.
    Hiroi, S.
    Hirayama, M.
    Seino, Y.
    DIABETES OBESITY & METABOLISM, 2011, 13 (11): : 1028 - 1035
  • [36] Delgocitinib ointment in pediatric patients with atopic dermatitis: A phase 3, randomized, double-blind, vehicle-controlled study and an open-label, long-term extension study
    Nakagawa, Hidemi
    Nemoto, Osamu
    Igarashi, Atsuyuki
    Saeki, Hidehisa
    Kabashima, Kenji
    Oda, Manabu
    Nagata, Takeshi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB52 - AB52
  • [37] Efficacy and safety of teneligliptin added to glimepiride in Japanese patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled study with an open-label, long-term extension
    Kadowaki, T.
    Kondo, K.
    DIABETES OBESITY & METABOLISM, 2014, 16 (05): : 418 - 425
  • [38] Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study
    Seino, Y.
    Miyata, Y.
    Hiroi, S.
    Hirayama, M.
    Kaku, K.
    DIABETES OBESITY & METABOLISM, 2012, 14 (10): : 927 - 936
  • [39] Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
    Barratt, Jonathan
    Barbour, Sean
    Brenner, Robert
    Cooper, Kerry
    Wei, Xuelian
    Eren, Necmi
    Floege, Juergen
    Jha, Vivekanand
    Kim, Sung Gyun
    Maes, Bart
    Phoon, Richard K. S.
    Singh, Harmeet
    Tesar, Vladimir
    Lafayette, Richard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024,
  • [40] Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2TOUCHSTONE Study
    Sandborn, William J.
    Feagan, Brian G.
    Hanauer, Stephen
    Vermeire, Severine
    Ghosh, Subrata
    Liu, Wenzhong J.
    Petersen, AnnKatrin
    Charles, Lorna
    Huang, Vivian
    Usiskin, Keith
    Wolf, Douglas C.
    D'Haens, Geert
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (07): : 1120 - 1129
12345